Advertisement

Amarin CEO on FDA's approval of key heart drug

Amarin CEO on FDA's approval of key heart drug Amarin CEO and president John Thero joins CNBC's "Power Lunch" team to discuss the drug company's FDA approval for Vascepa, a drug designed to reduce the incidence of heart attacks and strokes in high-risk patients. Amarin boosted its 2020 financial outlook following news of the approval.

For access to live and exclusive video from CNBC subscribe to CNBC PRO:

» Subscribe to CNBC TV:
» Subscribe to CNBC:
» Subscribe to CNBC Classic:

Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.

Connect with CNBC News Online
Get the latest news:
Follow CNBC on LinkedIn:
Follow CNBC News on Facebook:
Follow CNBC News on Twitter:
Follow CNBC News on Instagram:

#CNBC
#CNBC TV

Power Lunch,CNBC,business news,finance stock,stock market,news channel,news station,breaking news,us news,world news,cable,cable news,finance news,money,money tips,financial news,stock market news,stocks,

Post a Comment

0 Comments